CZ20011642A3 - Léčivo pro prevenci progrese aterosklerózy u savců - Google Patents

Léčivo pro prevenci progrese aterosklerózy u savců

Info

Publication number
CZ20011642A3
CZ20011642A3 CZ20011642A CZ20011642A CZ20011642A3 CZ 20011642 A3 CZ20011642 A3 CZ 20011642A3 CZ 20011642 A CZ20011642 A CZ 20011642A CZ 20011642 A CZ20011642 A CZ 20011642A CZ 20011642 A3 CZ20011642 A3 CZ 20011642A3
Authority
CZ
Czechia
Prior art keywords
aliquot
progression
mammal
aterosclerosis
mammals
Prior art date
Application number
CZ20011642A
Other languages
English (en)
Inventor
Duncan J. Stewart
Original Assignee
Vasogen Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/304,262 external-priority patent/US6264646B1/en
Application filed by Vasogen Ireland Limited filed Critical Vasogen Ireland Limited
Publication of CZ20011642A3 publication Critical patent/CZ20011642A3/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023Agression treatment or altering
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrotherapy Devices (AREA)
  • Radiation-Therapy Devices (AREA)
CZ20011642A 1998-11-13 1999-11-15 Léčivo pro prevenci progrese aterosklerózy u savců CZ20011642A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19023698A 1998-11-13 1998-11-13
US09/304,262 US6264646B1 (en) 1998-11-13 1999-05-06 Method for preventing and reversing atherosclerosis in mammals

Publications (1)

Publication Number Publication Date
CZ20011642A3 true CZ20011642A3 (cs) 2002-06-12

Family

ID=26885899

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011642A CZ20011642A3 (cs) 1998-11-13 1999-11-15 Léčivo pro prevenci progrese aterosklerózy u savců

Country Status (16)

Country Link
EP (1) EP1128837B1 (cs)
JP (1) JP2002529510A (cs)
CN (1) CN1230182C (cs)
AT (1) ATE233093T1 (cs)
AU (1) AU768300B2 (cs)
BR (1) BR9915270A (cs)
CA (1) CA2348599A1 (cs)
CZ (1) CZ20011642A3 (cs)
DE (1) DE69905602T2 (cs)
DK (1) DK1128837T3 (cs)
EA (1) EA003421B1 (cs)
ES (1) ES2192885T3 (cs)
MX (1) MXPA01004801A (cs)
NO (1) NO20012311L (cs)
NZ (1) NZ511467A (cs)
WO (1) WO2000029003A2 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
DE60024114T2 (de) 1999-09-24 2006-08-03 Vasogen Ireland Ltd., Shannon Zusammensetzung zur behandlung von atherosklerose, welche ein statin und ex-vivo behandeltes blut enthält
CA2309417A1 (en) 2000-05-25 2001-11-25 Anthony E. Bolton Apoptotic entities for use in treatment of endothelium dysfunction disorders
WO2005097145A1 (en) * 2004-04-12 2005-10-20 Vasogen Ireland Limited Myocarditis treatment
WO2008000067A1 (en) * 2006-06-26 2008-01-03 Vasogen Ireland Limited Treatment of mild chronic heart failure in human patients
RU2475275C1 (ru) * 2011-08-08 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения облитерирующего атеросклероза артерий нижних конечностей
RU2475276C1 (ru) * 2011-08-09 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения облитерирующего атеросклероза артерий нижних конечностей
RU2475274C1 (ru) * 2011-08-09 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения атеросклероза артерий нижних конечностей

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD249143A3 (de) * 1985-03-20 1987-09-02 Ilmenau Tech Hochschule Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes
WO1993015778A1 (en) * 1992-02-07 1993-08-19 Anthony Ernest Bolton Method of inhibiting the aggregation of blood platelets
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases

Also Published As

Publication number Publication date
DE69905602T2 (de) 2003-10-09
CN1330549A (zh) 2002-01-09
MXPA01004801A (es) 2002-09-18
JP2002529510A (ja) 2002-09-10
DE69905602D1 (de) 2003-04-03
BR9915270A (pt) 2003-12-30
EP1128837B1 (en) 2003-02-26
EA200100543A1 (ru) 2001-10-22
EA003421B1 (ru) 2003-04-24
EP1128837A2 (en) 2001-09-05
WO2000029003A3 (en) 2000-08-31
NO20012311L (no) 2001-07-02
NZ511467A (en) 2002-12-20
ATE233093T1 (de) 2003-03-15
CN1230182C (zh) 2005-12-07
ES2192885T3 (es) 2003-10-16
NO20012311D0 (no) 2001-05-10
AU1145000A (en) 2000-06-05
DK1128837T3 (da) 2003-06-16
WO2000029003A2 (en) 2000-05-25
CA2348599A1 (en) 2000-05-25
AU768300B2 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
GB9807639D0 (en) Anti-inflammatory agents
CA2400801A1 (en) Treatment of congestive heart failure by pretreated autologous blood
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
EA199800667A1 (ru) Новые фенантридины
BG106057A (en) Method of enhancing the efficacy of anti-tumour agents
CZ20011642A3 (cs) Léčivo pro prevenci progrese aterosklerózy u savců
ZA981609B (en) Method of treating a tumor
WO1999012951A8 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
MY120527A (en) Disposable absorbent undergarment.
EP0630412A4 (en) METHOD FOR IDENTIFYING AND TREATING ABNORMAL CELLS.
AU4779599A (en) Methods of inhibiting (helicobacter pylori)
SE9803079D0 (sv) Sätt och anordning vid värmebehandling av kroppsvävnad
EA199800819A1 (ru) Способ лечения биполярного расстройства
IL139303A0 (en) Treatment of arthritis and other similar conditions
WO2006007710A3 (en) Acute inflammatory condition treatment
NZ515727A (en) Aminotetralin derivative for the therapy of cardiovascular diseases
AU7500200A (en) Combined therapies for atherosclerosis treatment
ZA981558B (en) Inclusion complexes in aqueous solution
AU3145400A (en) Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
UA30521A (uk) Спосіб лікування доброякісної гіперплазії передміхурової залози у поєднанні з хронічним калькульозним простатитом
MX9701533A (es) Procedimiento para reducir lesiones en tejidos asociadas con isquemia no cardiaca.
UA32153A (uk) Спосіб формування трансплантату для зведення на промежину при черевно-анальних резекціях прямої кишки
UA43400C2 (uk) Спосіб підсилення рівня електричного сигналу
UA32157A (uk) Спосіб лікування діабетичної ретинопатії
UA32303A (uk) Спосіб лікування папіломатозу